JPWO2019148037A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019148037A5
JPWO2019148037A5 JP2020540721A JP2020540721A JPWO2019148037A5 JP WO2019148037 A5 JPWO2019148037 A5 JP WO2019148037A5 JP 2020540721 A JP2020540721 A JP 2020540721A JP 2020540721 A JP2020540721 A JP 2020540721A JP WO2019148037 A5 JPWO2019148037 A5 JP WO2019148037A5
Authority
JP
Japan
Prior art keywords
nanobodies
ecm
composition
epitopes
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020540721A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512071A (ja
JP7644441B2 (ja
JP2021512071A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/015290 external-priority patent/WO2019148037A1/en
Publication of JP2021512071A publication Critical patent/JP2021512071A/ja
Publication of JP2021512071A5 publication Critical patent/JP2021512071A5/ja
Publication of JPWO2019148037A5 publication Critical patent/JPWO2019148037A5/ja
Priority to JP2024115829A priority Critical patent/JP2025003912A/ja
Application granted granted Critical
Publication of JP7644441B2 publication Critical patent/JP7644441B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020540721A 2018-01-25 2019-01-25 疾患におけるｅｃｍのナノボディに基づく画像化および標的化ならびに開発 Active JP7644441B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024115829A JP2025003912A (ja) 2018-01-25 2024-07-19 疾患におけるｅｃｍのナノボディに基づく画像化および標的化ならびに開発

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862621811P 2018-01-25 2018-01-25
US62/621,811 2018-01-25
PCT/US2019/015290 WO2019148037A1 (en) 2018-01-25 2019-01-25 Nanobody based imaging and targeting of ecm in disease and development

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024115829A Division JP2025003912A (ja) 2018-01-25 2024-07-19 疾患におけるｅｃｍのナノボディに基づく画像化および標的化ならびに開発

Publications (4)

Publication Number Publication Date
JP2021512071A JP2021512071A (ja) 2021-05-13
JP2021512071A5 JP2021512071A5 (https=) 2022-02-02
JPWO2019148037A5 true JPWO2019148037A5 (https=) 2022-02-02
JP7644441B2 JP7644441B2 (ja) 2025-03-12

Family

ID=67299765

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020540721A Active JP7644441B2 (ja) 2018-01-25 2019-01-25 疾患におけるｅｃｍのナノボディに基づく画像化および標的化ならびに開発
JP2024115829A Pending JP2025003912A (ja) 2018-01-25 2024-07-19 疾患におけるｅｃｍのナノボディに基づく画像化および標的化ならびに開発

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024115829A Pending JP2025003912A (ja) 2018-01-25 2024-07-19 疾患におけるｅｃｍのナノボディに基づく画像化および標的化ならびに開発

Country Status (5)

Country Link
US (3) US11597769B2 (https=)
EP (1) EP3743443A4 (https=)
JP (2) JP7644441B2 (https=)
CN (1) CN112218890A (https=)
WO (1) WO2019148037A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112218890A (zh) 2018-01-25 2021-01-12 麻省理工学院 在疾病和发展中基于纳米抗体的ecm成像和靶向
EP4047016A1 (en) 2021-02-19 2022-08-24 Université de Strasbourg Anti-tenascin-c (tnc) single-domain antibodies (nanobodies) and use thereof
CN113151177B (zh) * 2021-05-21 2023-11-03 四川大学华西医院 乳腺或乳腺癌组织脱细胞基质及其制备方法和用途
US20240238451A1 (en) * 2021-05-28 2024-07-18 Albert Einstein College Of Medicine Single-domain antigen-dependent antibody-like fusion proteins
CN119095870A (zh) * 2022-03-21 2024-12-06 香港理工大学 肽双特异性抗体及其制备方法和应用
CN117624360A (zh) * 2022-08-26 2024-03-01 南京融捷康生物科技有限公司 一种抗trem2的单域抗体及其用途
IL319909A (en) * 2022-12-30 2025-05-01 Remegen Shanghai Co Ltd Bispecific antibody and its use
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
WO2025175132A1 (en) * 2024-02-15 2025-08-21 Board Of Regents, The University Of Texas System Methods for selecting triple-negative breast cancer patients for targeted therapy using tumor-specific total mrna expression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076456A2 (en) * 1999-06-14 2000-12-21 The General Hospital Corporation Modulators of fibrosis
US9320792B2 (en) * 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
CA2723842A1 (en) * 2008-05-09 2009-11-12 Peter Vanlandschoot Amino acid sequences directed against integrins and uses thereof
EP2970426B1 (en) * 2013-03-15 2019-08-28 Michael C. Milone Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
CN109563141A (zh) * 2016-05-13 2019-04-02 奥里尼斯生物科学公司 对非细胞结构的治疗性靶向
MX2019000641A (es) * 2016-07-15 2019-06-10 Poseida Therapeutics Inc Composiciones de mucina1-receptor de antigeno quimerico y metodos para su uso.
CN112218890A (zh) 2018-01-25 2021-01-12 麻省理工学院 在疾病和发展中基于纳米抗体的ecm成像和靶向

Similar Documents

Publication Publication Date Title
JP2021512071A5 (https=)
JPWO2019148037A5 (https=)
JPWO2020017835A5 (https=)
JP2005281687A5 (https=)
JP2007051159A5 (https=)
JP2010530846A5 (https=)
JP2009263366A5 (https=)
JP2005529175A5 (https=)
JP2023013438A5 (https=)
JPWO2021108298A5 (https=)
JP2010539414A5 (https=)
JP2011505843A5 (https=)
JP2024059744A5 (ja) ブプロピオン、および、テトラベナジン、アルファ－ジヒドロテトラベナジン、またはベータ－ジヒドロテトラベナジンを含む組成物
CN201805987U (zh) 一种新型保暖面料
CN218842093U (zh) 一种蜡烛棉签
CN207484156U (zh) 一种高分子防褶皱人造革
JP2005284241A5 (https=)
JPWO2021134045A5 (https=)
TWD239716S (zh) 髮刷
TWD240913S (zh) 探針
CN309727667S (zh) 垫片（草帽式）
JP2022071635A5 (https=)
JP2005179366A5 (https=)
CN206833780U (zh) 层粘连蛋白结构模型教具
TWD241459S (zh) 串流裝置